Literature DB >> 29402404

Prognostic value of suPAR and hs-CRP on cardiovascular disease.

Marie Zöga Diederichsen1, Søren Zöga Diederichsen2, Hans Mickley3, Flemming Hald Steffensen4, Jess Lambrechtsen5, Niels Peter Rønnow Sand6, Kent Lodberg Christensen7, Michael Hecht Olsen8, Axel Diederichsen9, Mette Hjortdal Grønhøj3.   

Abstract

BACKGROUND AND AIMS: Studies have shown that soluble urokinase Plasminogen Activator Receptor (suPAR) and CRP (both inflammatory markers) and coronary artery calcification (CAC) are independent risk predictors for cardiovascular (CV) disease. The aim of this study is to assess whether suPAR and CRP have an increased predictive prognostic value beyond the traditional CV risk factors and the CAC score.
METHODS: A population sample of 1179 subjects, free of CV disease was included. The subjects underwent traditional CV risk evaluation, CAC assessment and blood sampling for suPAR and CRP. CV events were extracted from The Danish National Patient Register after 6.5 years. The additive values of suPAR and CRP were evaluated by unadjusted Kaplan Meier analysis, adjusted hazard ratio and ROCAUC models.
RESULTS: 1179 participants (47.6% males, mean age 55 years) were included. 73 events occurred. In Kaplan Meier analyses, suPAR and CRP were significantly associated with CV events (p = 0.03 and p = 0.002). Adjusted for the CV risk factors and the CAC score, the hazard ratios for suPAR and CRP were 1.17 (95% confidence interval [CI] 1.01-1.34) and 1.04 (95% CI 1.01-1.06), respectively. suPAR was associated with a substantial risk among women (2.03; 95% CI 1.45-2.84) and 60-year-old subjects (1.44; 95% CI 1.09-1.90). By ROCAUC, neither suPAR nor CRP provided significant estimates (0.7100 and 0.7054) compared to the traditionally CV risk factors (0.6952, p = 0.24 and p = 0.16) and CAC score (0.7481, p = 0.33 and p = 0.32).
CONCLUSIONS: Adjusted for traditional CV risk factors and CAC score, suPAR and CRP were of minor importance in risk prediction.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Cardiovascular disease; Cardiovascular risk factors; Coronary artery calcification; High-sensitive C-reactive-protein; Inflammatory markers; Soluble urokinase plasminogen activator receptor

Mesh:

Substances:

Year:  2018        PMID: 29402404     DOI: 10.1016/j.atherosclerosis.2018.01.029

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  6 in total

1.  Electrochemical aptasensor based on anisotropically modified (Janus-type) gold nanoparticles for determination of C-reactive protein.

Authors:  Anabel Villalonga; Alfredo Sánchez; Diana Vilela; Beatriz Mayol; Paloma Martínez-Ruíz; Reynaldo Villalonga
Journal:  Mikrochim Acta       Date:  2022-08-02       Impact factor: 6.408

2.  Statins and C-reactive protein: in silico evidence on direct interaction.

Authors:  Neda Shakour; Massimiliano Ruscica; Farzin Hadizadeh; Cesare Cirtori; Maciej Banach; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Arch Med Sci       Date:  2020-11-02       Impact factor: 3.318

3.  Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI.

Authors:  Tariq U Azam; Husam R Shadid; Pennelope Blakely; Patrick O'Hayer; Hanna Berlin; Michael Pan; Peiyao Zhao; Lili Zhao; Subramaniam Pennathur; Rodica Pop-Busui; Izzet Altintas; Jens Tingleff; Marius A Stauning; Ove Andersen; Maria-Evangelia Adami; Nicky Solomonidi; Maria Tsilika; Pinkus Tober-Lau; Eleni Arnaoutoglou; Verena Keitel; Frank Tacke; Athanasios Chalkias; Sven H Loosen; Evangelos J Giamarellos-Bourboulis; Jesper Eugen-Olsen; Jochen Reiser; Salim S Hayek
Journal:  J Am Soc Nephrol       Date:  2020-09-22       Impact factor: 10.121

4.  Complement component 7 is associated with total- and cardiac death in chest-pain patients with suspected acute coronary syndrome.

Authors:  Reidun Aarsetøy; Thor Ueland; Pål Aukrust; Annika E Michelsen; Ricardo Leon de la Fuente; Heidi Grundt; Harry Staines; Ottar Nygaard; Dennis W T Nilsen
Journal:  BMC Cardiovasc Disord       Date:  2021-10-14       Impact factor: 2.298

Review 5.  Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation.

Authors:  Line Jee Hartmann Rasmussen; Jens Emil Vang Petersen; Jesper Eugen-Olsen
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

Review 6.  Recognized and Potentially New Biomarkers-Their Role in Diagnosis and Prognosis of Cardiovascular Disease.

Authors:  Weronika Bargieł; Katarzyna Cierpiszewska; Klara Maruszczak; Anna Pakuła; Dominika Szwankowska; Aleksandra Wrzesińska; Łukasz Gutowski; Dorota Formanowicz
Journal:  Medicina (Kaunas)       Date:  2021-07-08       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.